Hostname: page-component-7b7567c8c-2rsb6 Total loading time: 0 Render date: 2026-11-12T20:59:00.076Z Has data issue: false hasContentIssue false

Nontuberculous mycobacteria infections after cardiothoracic surgery with cardiopulmonary bypass among Medicare beneficiaries, 2009–2021

Published online by Cambridge University Press:  23 June 2026

Emily Ussery
Affiliation:
Centers for Disease Control and Prevention
Austin Penna
Affiliation:
Centers for Disease Control and Prevention
Kelly Hatfield
Affiliation:
Centers for Disease Control and Prevention
Joseph Lutgring
Affiliation:
Centers for Disease Control and Prevention
Ryan Fagan
Affiliation:
CDC
Sujan Reddy
Affiliation:
CDC
Kiran Perkins
Affiliation:
CDC

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Background: Nontuberculous mycobacteria (NTM) have caused serious infections following cardiothoracic surgery. In 2015, the first reports of NTM infections attributed to heater-cooler devices used during cardiopulmonary bypass (CPB) led to a prolonged international response. Surveillance and clinical management of these infections is challenging due to the long period (approximately 13–26 months) between exposure and disease presentation. Our objective was to describe the frequency and clinical outcomes of NTM infections following surgery with CPB among U.S. Medicare beneficiaries. Methods: We used Centers for Medicare & Medicaid Services claims data for Medicare fee-for-service beneficiaries. The study included adults who had (a) an inpatient claim with a procedure code for surgery requiring CPB between 2009–2021, and (b) an inpatient claim with a non-pulmonary NTM diagnosis code within two years after the index surgery. For beneficiaries with multiple surgeries in 2009–2021, only the first was included. Beneficiaries with an NTM diagnosis code on a claim in the year before the surgery were excluded. Demographic and clinical characteristics among cases and clinical outcomes in the two years after the index surgery were described. Results: Overall, 349 NTM case-patients with an index cardiothoracic surgery between 2009-2021 were identified. Cases had a median age of 70 years (interquartile range [IQR]: 65–77) (Table). The number of cases peaked in 2014 (n=40) and was lowest in 2018 (n=16) (Figure). The largest proportion of index surgeries were coronary artery bypass graft surgeries (45.0%), followed by cardiac valve surgeries (33.8%) and ventricular assist device surgeries (19.5%). The median time from index surgery to the first hospitalization with an NTM diagnosis code was 195 days (IQR: 75–416), and 26.9% of cases (n=94) had a diagnosis code for a serious infection (sepsis, endocarditis, or other bloodstream infection) at the time of the NTM diagnosis. During the two years after the index surgery, cases had a median of 4 inpatient hospitalizations and the median cumulative length of inpatient stays was 41 days (IQR: 18–77); 129 cases (37.0%) died, including 51 deaths among cases with a serious infection (54.3%). Conclusions: NTM infections following cardiothoracic surgery involving CPB continue to be identified despite heater-cooler device-related interventions. Although this claims-based analysis was unable to assess detailed clinical manifestations or cause of infection, the results suggest a need for continued attention to NTM prevention strategies in patients requiring CPB surgery to prevent these severe infections that are associated with multiple subsequent hospitalizations and high mortality.

A table summarizing demographic, clinical characteristics, and outcomes of Medicare beneficiaries with NTM infections post-surgery.

A bar graph showing the number of Medicare beneficiaries who had a nontuberculous mycobacteria infection within two years of an index cardiothoracic surgery, by year of the index surgery, from 2009 to 2021.

Information

Type
Public Health
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America